Controversial Cholesterol Drug Reduces Risk of Heart Disease
November 18, 2014
(Scientific American) – A popular but controversial cholesterol drug reduces the risk of cardiovascular events such as heart attacks and stroke, researchers say. The drug, called ezetimibe, had been shower to lower cholesterol levels, but its ability to combat heart disease was in dispute. But now ezetimibe, made by Merck of Whitehouse Station, New Jersey, has been found to lower the number of cardiovascular events by 6.4% when given with another cholesterol drug.